🆕 @gohealio.bsky.social podcast drop!

🎙️In the latest episode of Beneath the Surface, @joelgel.bsky.social talks with Lauren Orenstein, MD, of @emorydeptofmed.bsky.social about how to diagnose and manage hidradenitis suppurativa.

Take a listen 👇

www.healio.com/news/dermato...

🎥 Sneak peek: An episode of @gohealio.bsky.social Beneath the Surface was recorded live here in Denver at #AAD2026! 🏔️

🗣️ @joelgel.bsky.social talks with Joseph Merola, MD, about TOGETHER-PsA, a trial assessing Taltz + Zepbound for adults with PsA and obesity.

Video and article coming soon!

👋 Catching up with Healio Dermatology Chief Medical Editor @joelgel.bsky.social at #AAD2026 in Denver! 🏔️

📝 Dr. Gelfand served as a moderator during morning and afternoon late breaking research sessions.

@gohealio.bsky.social will have reports from these sessions coming soon — stay tuned!

🚨 Approximately 6 million Americans a year develop a chronic wound.🚨

🔎 In the latest Beneath the Surface episode, @joelgel.bsky.social and Robert S. Kirsner, MD, PhD, of University of Miami, discuss diagnosis, treatment and more.

@gohealio.bsky.social

www.healio.com/news/dermato...

How Stand Up For Science is trying to 'pull every lever' to win over the public Stand Up For Science has become a formal organization and adopted a new strategy that's more confrontational with grassroots tactics

'Stand Up For Science' moving from protest day to political player | STAT

The emerging role of GLP-1s in inflammatory diseases

❓Can Ozempic treat inflammatory diseases❓

🎙️In the latest Beneath the Surface podcast, @joelgel.bsky.social talks with Fatima Cody Stanford, MD, and Philip Mease, MD, about the role of GLP-1s in dermatology, rheumatology and beyond.

Listen ⬇️

@gohealio.bsky.social

www.healio.com/news/dermato...

Histogram showing first-year monetized QALY improvements with the label "A Biologic only." The x-axis represents Monetized QALY gains ($), and the y-axis represents Simulated patients (No.). Mean (SD) is $24107 ($7916).

In this economic evaluation, #psoriasis treatments provided substantial patient value, with biologics delivering the largest mean gains, phototherapy remaining effective but underused, and step-therapy regimens achieving comparable efficacy at lower cost. ja.ma/4l56iN1

See what @joelgel.bsky.social, Deputy Editor for Clinical Research & Epidemiology has been reading:
www.jidonline.org/article/S002...

#DermatologyJournal #dermatology #dermsky #dermatologists #dermresearch #dermscience #dermatologyresearch

A Conversation with Dr. Jay Bhattacharya: On the NIH, CDC, Funding, DEI & His Vision For Doing Science Podcast Episode · Why Should I Trust You? · February 26 · 1h 2m

A podcast with Director Bhattacharya worth listening to...

podcasts.apple.com/us/podcast/w...

Fair questions and good and serious engagement about important issues.

I will post more later, once I have been through it again.

How to recognize and diagnose measles with Amy Paller, MD

🚨New podcast drop! 🚨

🎙️In the latest episode of Beneath the Surface, @joelgel.bsky.social talks with Amy Paller, MD, of @feinberg.northwestern.edu about how to recognize and diagnose #measles.

Check it out below 👇

www.healio.com/news/dermato...

@gohealio.bsky.social @healioid.bsky.social

Please take a moment to read Erwin Tschachler's, JID Editor, Editorial in the January issue:
doi.org/10.1016/j.ji...
We would like to thank all of our reviewers for their valuable work during 2025!
#DermatologyJournal #dermatology #dermsky #dermatologists #dermresearch #dermscience #peerreview

🤝It was great to attend the Dermatology in Pharma Educational Collaborative, hosted by @joelgel.bsky.social & the Penn Center for Clinical Sciences in Dermatology!

📰Read my interview with DPEC keynote speaker Sean Hennessy, PharmD, PhD! 🔗⬇️

@gohealio.bsky.social

www.healio.com/news/dermato...

A commentary by Luis Puig, "Repurposing Roflumilast and the Emerging Landscape of PDE4 Inhibition in Psoriasis" https://doi.org/10.1016/j.jid.2025.06.1293 #JIDJournal #DermatologyJournal #dermatology #dermatologists #dermresearch #dermscience #psoriasis #dermsky

🔎 In a @gohealio.bsky.social Beneath the Surface series, @joelgel.bsky.social does a deep dive into #HS w/ Lauren Orenstein, MD.

Check out all three episodes! 👇

🎙️Diagnosis: www.healio.com/news/dermato...
🎙️Treatments: www.healio.com/news/dermato...
🎙️Pain management: www.healio.com/news/dermato...

‘Exciting’ brepocitinib data may open door for first targeted dermatomyositis drug Treatment with once-daily brepocitinib improved skin disease, muscle and physical function measures for adults with dermatomyositis while minimizing steroid burden, with benefits as early as 4 weeks a...

🆕phase 3 VALOR data:

💊Brepocitinib, an oral TYK2/JAK 1 inhibitor, improved skin disease, muscle strength & functional disability for people with #dermatomyositis.

📰 My interview with Anthony Fernandez, MD, of @clevelandclinic.bsky.social🔗⬇️

@gohealio.bsky.social

www.healio.com/news/dermato...

👏 Congratulations to former Becker @wellcometrust.bsky.social ICD PhD student @megtriesscience.bsky.social on her first-author paper in Science Signaling!

Beneath the Surface: The challenge of diagnosing hidradenitis suppurativa Hidradenitis suppurativa is a chronic autoinflammatory condition that is estimated to affect approximately 1% to 4% of people in the United States, often characterized by painful lesions that can be d...

A new Beneath the Surface episode is live!

For the first of this 3-part series, @joelgel.bsky.social talks with Lauren Orenstein, MD, of @emoryuniversity.bsky.social about the signs & symptoms of HS.

🎥Check out the video or read the article 👇

@gohealio.bsky.social

www.healio.com/news/dermato...

Discussing possible JAK-inhibition, Down syndrome link with Emma Guttman-Yassky, MD, PhD

📣A new @gohealio.bsky.social Beneath the Surface podcast is live!

🎙️In this episode, @joelgel.bsky.social talks with Emma Guttman-Yassky about inflammatory diseases, the association between JAK inhibition and Down syndrome comorbidities and more.

👇Check it out 👇

www.healio.com/news/dermato...

A deep dive into iPledge changes with John Barbieri, MD

A 🆕 Beneath the Surface podcast is live!

🎙️In this episode, @joelgel.bsky.social talks with @drjohnbarbieri.bsky.social about FDA’s 2023 proposed changes to the iPledge system & impacts of trials & treatments on patients w/ hormonal acne.

www.healio.com/news/dermato...

@gohealio.bsky.social

Read the Editorial from Ramessur and @joelgel.bsky.social in the September issue:
Facing Our FAERS: Disproportionality Analyses, Signal Detection, and Interpretation
doi.org/10.1016/j.ji...
#DermatologyJournal #dermatology #dermsky #dermatologists #dermresearch #dermscience #dermatologyresearch

Beneath the Surface: The vital role of dermatologists with Susan C. Taylor, MD, FAAD The American Academy of Dermatology, currently led by Susan C. Taylor, MD, FAAD, is supporting its members during a time of rapid change and a challenging reimbursement environment, both complicating ...

📢 “Medicare physician practice payment reform is our #1 priority.”

🎥 In this special edition of @gohealio.bsky.social's Beneath the Surface on LinkedIn LIVE, Susan C. Taylor, MD, FAAD, talks dermatology’s impact & AAD's current initiatives w/ @joelgel.bsky.social!

⬇️
www.healio.com/news/dermato...

Q&A: How to choose an LED mask for acne care At-home LED face masks, especially those that combine red and blue light, can complement prescription and over-the-counter acne treatments, but new data suggest consumers should be cautious before sel...

❓Can at-home LED masks treat #acne❓

In a @gohealio.bsky.social Q&A, I spoke with @drjohnbarbieri.bsky.social about:

💡How masks may help with mild acne
💡Using masks with other acne treatments
💡Higher cost 💸does not 🟰 a more effective device

@jamadermatology.com

www.healio.com/news/dermato...

FDA approves Anzupgo for chronic hand eczema The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond to or cannot receive topical corticosteroids, Leo Pharma announced in a pre...

🚨Breaking: @fda.gov approved Anzupgo, a JAK inhibitor and nonsteroidal option for moderate to severe chronic hand eczema.

🔑"Importantly, it fills a treatment gap for patients who might otherwise require systemic therapy," Melinda Gooderham told @gohealio.bsky.social

www.healio.com/news/dermato...

Q&A: Allergic to the sun? Henry Lim, MD explains polymorphous light eruption An extended day in the sun can be anything but relaxing for those who develop polymorphous light eruption, an uncomfortable, often itchy sun rash that can persist for several days. Polymorphous light ...

☀️ Check out the second installment of our Healio Dermatology summer skin series!

🗣️ In this @gohealio.bsky.social Q&A, I spoke with Henry Lim, MD, of Henry Ford Health about polymorphous light eruption, a skin rash that develops after sun exposure. ☀️

🔗👇

www.healio.com/news/dermato...

Join me on Thu, Jul 17, 2025, 2:30 PM EST for a #Healio LinkedIn Live with #AAD President Susan Taylor where we'll discuss how #dermatologists can navigate the rapidly changing world & get better outcomes for patients while having more satisfying careers.
Register at: lnkd.in/dnhsGnpF
#DermSky

Join @joelgel.bsky.social and AAD President Susan C. Taylor, MD, FAAD, for our July LinkedIn Live event!🎥

They will explore:

✨How emerging technologies and #AI are transforming #dermatology;

✨How the specialty can stay ahead of the curve; and more!

Register ⬇:

www.linkedin.com/events/navig...

Navigating the rapidly changing world of dermatology with AAD President | LinkedIn Join Healio | Dermatology’s Chief Medical Editor, Joel M. Gelfand, MD, MSCE, for a LinkedIn livestream! He will be joined by Susan C. Taylor, MD, FAAD to explore how emerging technologies and AI are t...

Hey #Dermsky! Join me for this @linkedin.com LIVE Thursday, July 17, 2025, 2:30 PM EST. This will be a critical conversation about how #dermatology can thrive in a rapidly changing world. Register at: lnkd.in/ejXw94v7
@gohealio.bsky.social

Not unusual to go from not discussed to funded on the resubmission. Albeit that was in a different era, circa 2024

Ugh. Not Discussed. The worst tattoo

National Psoriasis Foundation tops $1.5 million fundraising goal with Commit to Cure gala The National Psoriasis Foundation raised more than $1.5 million during its annual Commit to Cure gala, breaking previous fundraising records and furthering ongoing efforts to find a cure for psoriatic...

🔎 This year’s National Psoriasis Foundation Commit to Cure gala raised more than 🎉$1.5 million🎉 for #psoriasis research, breaking past records. 🎉

🏆Honorees this year included @gohealio.bsky.social Dermatology Chief Medical Editor @joelgel.bsky.social

Read more ⬇️

www.healio.com/news/dermato...